ProMedica Toledo Hospital — Toledo, Ohio

Public research footprint of ProMedica Toledo Hospital, compiled from the ClinicalTrials.gov public registry.

251

Registered studies

134

Active

Recruiting now

101

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Ovarian Carcinoma · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Stage IV Cutaneous Melanoma AJCC v6 and v7 · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma

Recently updated registry entries

NCT03701282 — Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited… (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT02003222 — Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at ProMedica Toledo Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.